Drugs / Bupivicaine Hydrochloride
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01995045 Background | Jul 2012 → Dec 2015 | proliferative vitreoretinopathy, retinal detachment, retinoschisis | Emory University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bupivicaine Hydrochloride | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01995045 ↗ |
| Known as | Bupivicaine | “Drug: Bupivicaine” NCT01995045 ↗ |
| Route | Other | “retrobulbar injection” NCT01995045 ↗ |